Table I.
Case | Gender | Age | Course | Platelet count | Platelet (after) | Onset | Symptoms | Treatment | Result |
---|---|---|---|---|---|---|---|---|---|
1 | M | 56 | N/K | 99000 | 6000 | 5 h | Purpura, gingivorrhagia | Steroids, transfusion | Recovery |
2 | M | 52 | 9 | 182000 | 17000 | 1 day | Bleeding | Transfusion | Recovery |
3 | F | 40 | 13 | 153000 | 80000 | 1 day | Back pain | No | Recovery |
4 | F | 70 | 19 | 432000 | 2000 | 4 h | Skin rash | Transfusion | Recovery |
5 | M | 60 | 14 | 143000 | 2000 | 1 h | Hematemesis | Transfusion | Recovery |
6 | F | 79 | 15 | 221000 | 5000 | 4 h | Bleeding, purpura | Steroids, transfusion | Recovery |
7 | F | 38 | 17 | 150000 | 13000 | 2 days | Abdominal pain, petechial hemorrhages | Transfusion | Recovery |
8 | F | 55 | 10 | 136000 | 6000 | 24 h | Not mentioned | Transfusion | Recovery |
9 | F | 59 | 20 | 253000 | 5000 | 8 h | Purpura, gingivorrhagia | Steroids, transfusion | Recovery |
10 | M | 64 | 24 | 163000 | 4000 | 1 h | Back pain | Transfusion | Death |
11 | F | 57 | 11 | 89000 | 17000 | 17 h | Bleeding | Transfusion | Recovery |
12 | F | 50 | 15 | 119000 | 5000 | 7 h | Purpura, gingivorrhagia | Steroids, transfusion | Recovery |
13 | M | 48 | 21 | 94000 | 1000 | 7 h | Purpura | Steroids, transfusion | Recovery |
14 | F | 59 | 12 | 151000 | 20000 | 1 day | Petechial hemorrhages | Steroids, transfusion | Recovery |
15 | M | 60 | 3 | 226000 | 4000 | 1 day | Petechial hemorrhages, tongue hematoma | IVIG infusion | Recovery |
16 | F | 66 | 3 | 87000 | 66000 | 5–10 min | Skin rash | Steroids | Recovery |
17 | F | 55 | 13 | 136000 | 8000 | Immediately | Petechial hemorrhages | Steroids | Recovery |
18 | M | 78 | 17 | 104000 | 15000 | 1.5 h | Coma | Steroids, transfusion, G-CSF | Death |
19 | F | 66 | 25 | N/K | 22000 | 4 days | Fever up, general fatigue | Transfusion, HD | Recovery |
Our case | F | 55 | 9 | 135000 | 35000 | 2 days | Bleeding | Steroids, transfusion | Recovery |
NK, not known; G-CSF, granulocyte colony-stimulating factor; HD, hemodialysis; IVIG, intravenous immunoglobulin.